Related Experiment Video
Updated: May 30, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Parental prescription opioid abuse and the impact on children
Lisham Ashrafioun1, Christina M Dambra, Richard D Blondell
1Department of Family Medicine, Erie County Medical Center, University at Buffalo, Buffalo, NY, USA. Lashraf@bgsu.edu
Insights
Parental opioid abuse characteristics, including non-medical prescription opioid use and criminal history, are linked to greater child global impairment. Identifying these factors helps clinicians assess children needing mental health services.
Area of Science:
- Child Psychology
- Addiction Medicine
- Public Health
Background:
- Opioid abuse among parents poses risks to child well-being.
- Understanding parental factors associated with child impairment is crucial for intervention.
Purpose of the Study:
- To identify specific characteristics of opioid-abusing parents associated with increased global impairment in their children.
- To inform clinical assessments for children at risk due to parental substance abuse.
Main Methods:
- 14 parents in a chemical dependency unit with children aged 4-17 participated.
- Child global impairment was assessed using the parent-reported Brief Impairment Scale (BIS).
- Regression analyses identified parental characteristics linked to child BIS scores.
Main Results:
- Moderate global impairment was observed in the children (mean BIS score 15.5).
- Parental non-medical prescription opioid acquisition, increased arrests, intravenous drug use, and prior substance abuse treatment episodes were associated with higher child BIS scores.
Conclusions:
- Specific parental opioid abuse indicators can help identify children at risk for impairment.
- Early identification facilitates timely access to necessary mental health services for affected children.
- Further research is needed due to study limitations.
Objective:
The purpose of this study was to identify which characteristics of opioid-abusing parents were associated with greater global impairment of their children.
Methods:
Data regarding participant demographics, drug use, and child demographics were collected from 14 patients in a chemical dependency unit who had at least one child between the ages of 4 and 17, inclusive. Child global impairment was measured by the parents' report using the Brief Impairment Scale (BIS). Regression analyses were conducted to assess which parental characteristics were associated with child BIS scores.
Results:
The mean age of the 14 participants was approximately 40 years, 9 (64.3%) were women, and 12 (85.7%) were white. At the time of hospitalization, 12 (85.7%) had had prior substance abuse treatment, 9 (64.3%) had received prescription opioids through non-medical sources, and 9 (64.3%) had a criminal history. The mean BIS score of 24 children was 15.5, which is associated with moderate global impairment of function. Greater child BIS scores were associated with a number of parental characteristics, such as obtaining any prescription opioids through non-medical sources, having a greater number of arrests, previously using drugs intravenously, and having a greater number of prior substance abuse treatment episodes.
Conclusions:
By assessing these parental characteristics, clinicians may be able to assess children who are at risk for impairment and, in turn, may be in need of mental health services. Due to limitations of this study, further evaluation is needed.
Related Concept Videos
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Abuse and Addiction: Pharmacological Phenomena
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Pharmaceutical Poisoning: Potential Scenarios
